GLP-1 Cost Per Month: Pill vs Injection Compared

Start by writing the full name and form: pill, single-dose pen, multi-dose pen, or vial. Some names sound similar but price and access can differ a lot (for example, Wegovy pill vs Wegovy injection). If you are on tirzepatide, note whether it is Zepbound and whether you are using the KwikPen or another format. This step matters because “monthly cost” is not a single number across brands or delivery types.

Some pills have strict timing rules that can affect daily life, refill adherence, and how you plan morning routines. The Wegovy pill (oral semaglutide 25 mg) must be taken first thing in the morning with a small sip of water, at least 30 minutes before food, drinks, or other oral medicines. Foundayo (orforglipron) is a once-daily GLP-1 pill with no fasting or water restrictions and can be taken any time of day. These details do not change the sticker price, but they can change what feels “worth it” for you month to month.

If you are paying cash (or you are underinsured), use official manufacturer routes before relying on social media price claims. At the time of writing, TrumpRx.gov lists the lowest manufacturer self-pay prices and routes you to the maker’s channel (such as NovoCare or LillyDirect), but it is not insurance and prices can change often. Fall 2026 examples on that site included Wegovy pill $149, Wegovy pen $199, and Zepbound $299, varying by dose and subject to change. Always confirm current pricing and terms directly with the manufacturer or your pharmacist.

From July 1, 2026 through December 31, 2027, CMS is running the Medicare GLP-1 Bridge demonstration for certain Part D enrollees. Eligible members pay a $50/month copay that does not count toward the deductible or out-of-pocket maximum, and it can cover Wegovy (all forms), Foundayo, and Zepbound KwikPen. Prior authorization is required, with eligibility tied to age and BMI plus specific health conditions (for example, BMI thresholds and certain cardiovascular, kidney, blood-pressure conditions, or prediabetes and prior events). Coverage rules are personal, so confirm eligibility with your plan and your prescribing clinician.

For Foundayo, it is available via LillyDirect, telehealth, and retail pharmacies, and at launch the self-pay price started at $149/month for the lowest dose, with a commercial savings card as low as $25/month for eligible patients. For injectables, access can vary by pen type and pharmacy contracting; for example, Zepbound KwikPen is a multi-dose pen approved in February 2026, and one device holds a month of doses across all six strengths. Savings programs change often and have eligibility rules, so check the manufacturer site and your pharmacy’s ability to process the offer. If anything is unclear, ask the pharmacist to walk you through what will be billed today versus what might change after prior authorization.

Many people look at compounded versions when they are focused on monthly cost, but quality, legality, and coverage can vary. Be especially careful with products marketed online under names that are not FDA approved (for example, retatrutide is not approved as of this date and is not legally prescribable outside clinical trials). If you are considering compounded medication, use a licensed prescriber and a trusted pharmacy and ask direct questions about what ingredient is being used and how it is supplied. Do not rely on social posts as proof of safety, approval, or price stability.